Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ

$26.33

+$1.06 (4.19%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$25.56$26.50

Open $25.78

52 Week Range

$20.39$42.49

Previous Close $25.27

Market Cap1.21B

Volume410.13K

Avg Volume432.52K

P/E (TTM)10.96

EPS (TTM)$2.40

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for Amphastar Pharmaceuticals, Inc.

DEC152025

Amphastar Announces FDA Approval for Teriparatide Injection

Source: Accesswire•Yesterday

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") for teriparat...

NOV242025

Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference

Source: Accesswire•22 days ago

RANCHO CUCAMONGA, CA / ACCESS Newswire / November 24, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, will be participating in an Analyst-M...

NOV122025

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Source: Accesswire•34 days ago

RANCHO CUCAMONGA, CA / ACCESS Newswire / November 12, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will be participating in an Analyst-Moderated fi...

NOV62025

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025

Source: Accesswire•39 days ago

Reports Net Revenues of $191.8 million for the Three Months Ended September 30, 2025 GAAP net income of $17.4 million, or $0.37 per share, for the third quarter Adjusted non-GAAP net income of $44.7 million, or $0.93 per share, for the third quarter ...

OCT272025

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

Source: Accesswire•50 days ago

RANCHO CUCAMONGA, CA / ACCESS Newswire / October 27, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2025 ended September 30, 2025, after the market closes on Thursday, Nov...